<p style="margin-top:11px;text-indent:32px;text-autospace:ideograph-numeric;line-height:39px"><span style=";font-family:仿宋;font-size:21px"> 施美药业集团</span><span style=";font-family:仿宋;font-size:21px">是一家以研发为核心驱动力的创新型医药企业，</span><span style=";font-family:仿宋;font-size:21px">目前集团核心成员包括江西施美、山东创新、山东科新、广州施美、广东创新谷等。公司</span><span style=";font-family:仿宋;font-size:21px"><span style="font-family:仿宋">自成立以来，秉持</span><span style="font-family:仿宋">“施人以美、健康为本”的企业宗旨，专注于</span></span><span style=";font-family:仿宋;font-size:21px">高端</span><span style=";font-family:仿宋;font-size:21px">仿制药、改良型创新药、</span><span style=";font-family:仿宋;font-size:21px">自主</span><span style=";font-family:仿宋;font-size:21px">创新药的研发、生产及销售，</span><span style=";font-family:仿宋;font-size:21px">可</span><span style=";font-family:仿宋;font-size:21px">向客户提供自主研发技术成果转化</span><span style=";font-family:仿宋;font-size:21px">（</span><span style=";font-family:仿宋;font-size:21px">MAH</span><span style=";font-family:仿宋;font-size:21px">）</span><span style=";font-family:仿宋;font-size:21px"><span style="font-family:仿宋">、受托研发（</span><span style="font-family:仿宋">CRO）、定制化生产和委托加工（CDMO）等一站式综合服务。</span><span style="font-family:仿宋">公司始终高度重视技术研发平台化建设，围绕手性降三高药物等</span></span><span style=";font-family:仿宋;font-size:21px">七大产品管线</span><span style=";font-family:仿宋;font-size:21px">进行深入布局，搭建了以新型手性药物研发平台为代表的九大核心技术平台，形成了完善的医药研发体系，构建了自身独特的核心竞争优势。</span></p> <p style="margin-top:11px;text-indent:32px;text-autospace:ideograph-numeric;line-height:39px"><span style="font-family: 仿宋;letter-spacing: -0;font-size: 21px"><span style="font-family:仿宋">  经过多年发展，公司具备了从药学到临床</span><span style="font-family:仿宋">CRO、从原料到制剂CDMO的“四轮驱动”式综合服务能力。</span></span><span style=";font-family:仿宋;font-size:21px">公司</span><span style=";font-family:仿宋;font-size:21px">立足于自身的资源禀赋和技术优势，</span><span style=";font-family:仿宋;font-size:21px">坚持以终为始，以客户为中心，以临床价值、市场需求为导向，</span><span style=";font-family:仿宋;font-size:21px">牢牢</span><span style=";font-family:仿宋;font-size:21px"><span style="font-family:仿宋">树立</span><span style="font-family:仿宋">“以仿养创、以仿促创、仿中有创、仿创结合”的经营理念，</span></span><span style=";font-family:仿宋;font-size:21px">公司坚持有所为有所不为，既要拥抱集采，又要远离集采，院内院外互补，线上线下联动，以</span><span style=";font-family:仿宋;font-size:21px">“大品种</span><span style=";font-family:仿宋;font-size:21px">、</span><span style=";font-family:仿宋;font-size:21px"><span style="font-family:仿宋">大病种、大市场</span><span style="font-family:仿宋">”</span></span><span style=";font-family:仿宋;font-size:21px">慢性</span><span style=";font-family:仿宋;font-size:21px">疾病领域</span><span style=";font-family:仿宋;font-size:21px">为基本盘</span><span style=";font-family:仿宋;font-size:21px"><span style="font-family:仿宋">，通过</span><span style="font-family:仿宋">“首仿、抢仿、高难仿”的差异化研发策略，采用“自主立项、自行研发、自我申报、择机转让”的</span></span><span style=";font-family:仿宋;font-size:21px">独特</span><span style=";font-family:仿宋;font-size:21px">商业模式，形成了多环节、多领域的</span><span style=";font-family:仿宋;font-size:21px">研发、生产、</span><span style=";font-family:仿宋;font-size:21px">经营</span><span style=";font-family:仿宋;font-size:21px">和服务</span><span style=";font-family:仿宋;font-size:21px">能力。</span></p> <p><br></p>